IDEXX Laboratories, Inc. (IDXX) Enterprise Value (EV): $44.64B
The enterprise value (EV) for IDEXX Laboratories, Inc. (IDXX) is $44.64B as of Thursday, June 11, 2026.
IDXX Enterprise Value (EV) Metrics
ENTERPRISE VALUE (EV)
$44.64B
IDXX Competitors' Enterprise Value (EV)
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| IDEXX Laboratories, Inc. (IDXX) | $43.84B | $44.64B |
| Humana Inc. (HUM) | $44.54B | $39.59B |
| Agilent Technologies, Inc. (A) | $36.21B | $42.98B |
| Zoetis Inc. (ZTS) | $34.27B | $62.97B |
| Centene Corporation (CNC) | $32.26B | $21.10B |
| Medline Inc. (MDLN) | $31.40B | $44.73B |
| IQVIA Holdings Inc. (IQV) | $30.08B | $52.94B |
| Biogen Inc. (BIIB) | $28.94B | $29.76B |
| DexCom, Inc. (DXCM) | $28.92B | $26.37B |
| Veeva Systems Inc. (VEEV) | $26.31B | $32.05B |
Enterprise Value Calculation
Market Cap
$43.84B
Total Debt
$976.06M
Cash
$180.07M
Enterprise Value
$44.64B
EV-Based Valuation Multiples
Why use EV instead of Market Cap?
- EV accounts for debt - an acquirer must pay or assume it
- EV deducts cash - the acquirer effectively receives it
- EV enables fair comparison of companies with different capital structures
- EV-based ratios (EV/EBITDA, EV/Sales) are capital structure neutral
IDEXX Laboratories, Inc. Enterprise Value (EV) Formula & Definition
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
IDEXX Laboratories, Inc. Enterprise Value (EV) FAQ
- What is the enterprise value (EV) for IDEXX Laboratories, Inc. (IDXX)?
- The enterprise value (EV) for IDXX stock is $44.64B.
Related Metrics
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Jonathan J. Mazelsky